New cancer clinical trial: Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia

Published on: February 08, 2019 at 10:30PM

• Tweet
• Share
• Share
• Share
• Share